Log In
BCIQ
Print this Print this
 

SCY-078 (formerly MK-3118)

  Manage Alerts
Collapse Summary General Information
Company Scynexis Inc.
DescriptionSemi-synthetic derivative of enfumafungin, a beta 1,3-D-glucan synthase inhibitor
Molecular Target Beta 1,3-D-glucan synthase
Mechanism of ActionAntioxidant
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/16/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today